NUFYMCO BLA has been approved by the USFDA
27 December 2025

Zydus Life sciences strategic partnership with Bioeq for NUFYMCO

Bioeq AG, a Swiss biopharmaceutical company, and Zydus Lifesciences Limited , an innovation-led life-sciences company with an international presence, today announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, United Arab Emirates has entered into a strategic partnership with Bioeq, for the licensing, supply and commercialization of Bioeq`s Vascular Endothelial Growth Factor (VEGF) inhibitor NUFYMCO®, an interchangeable biosimilar of Lucentis®1 (Ranibizumab) for the U.S. market. The Biologics License Application (BLA) for NUFYMCO® has been approved by U.S.

26 December 2025
Advertisement for PG in Life Sciences, MSc, MS Pharm at NIPER - Salary Rs. 56,000 with HRA
Post Graduate Degree, including the integrated PG degree in Medicinal Chemistry or Life Sciences [M.Sc / MS (Pharm.) / Equivalent]
26 December 2025
Openings for Pharmacists (06 posts) under Ministry of Defence
B.Pharmacy from an recognized institute or 10+2 with Science streams from a recognized board and Approved Diploma in Pharmacy from an Institute recognized by the Pharmacy council of India and registered as Pharmacist under the Pharmacy Act 1948.
26 December 2025
Advertisement for M.Pharm, M.S Pharm, MSc as JRF at Lloyd Institute of Management and Technology (Pharm)
M.Pharm / M.S. (Pharm) / MSc.(Bioinformatics) with First Division. Anusandhan National Research Fellowship (ANRF), Govt, of India
26 December 2025
Life Sciences, Pharma Openings in Multidisciplinary Research Unit, SMIMER
BPharm; MSc. in any of the Life Science subjects minimum of 2 years experience of working in the research field.
26 December 2025
Advertisement for PG in Life Sciences, Biochemistry, Pharmaceutical Biotechnology at ICT Mumbai
M.Sc / M.Tech in Biotechnology / Biochemistry / Molecular Biology / Life Sciences / Pharmaceutical Biotechnology or allied disciplines.
26 December 2025
Openings for Pharmacy graduates at IIT (BHU)
Graduation in Science or Engineering or Technology or Pharmacy fields.
26 December 2025
Applications are open for Research Scientist at IASST - Biotechnology, Biochemistry, Life Sciences Apply
Essentially good academic record with First Class M.Sc. /M. Tech with a minimum 60% marks or equivalent CGPA in aggregate in Biotechnology/ Biochemistry / Molecular Biology/ Life Sciences/Zoology.
26 December 2025
Regional Centre for Biotechnology looking for Life Sciences candidates | Salary Rs. 66,000 month
Masters degree in Life Sciences or associated fields with National Eligibility Test NET qualification, with a minimum of 60% marks or equivalent grade.
26 December 2025
NIBMG Looking for Biotechnology or Life Sciences candidates
Graduate Degree in Biotechnology or any Life Sciences subject from a recognized University or equivalent.
26 December 2025
Inviting for MPharm, BPharm, MSc candidates in Quality Control at Zydus Lifesciences
Handling and Investigation of Incidence, OOS, OOT and OOC activities. Preparation of Investigation reports, Analytical test procedure, and SOP.
26 December 2025
Opportunity for BPharm to Join Sun Pharma - Production (OSD formulation)
Granulation / Compressior / Coating / Packing OSD formulation. Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world
26 December 2025
Interview for MPharm, BPharm, MSc in QC, R&D at Eris Therapeutics
Candidates must have good analytical skills for testing Finished Goods of different dosage form like Tablets, Capsules, Oral Suspension, Injectables and External preparation
26 December 2025
Interview for M.Pharm, B.Pharm, MSc in Production, QA, QC, Packing at RPG Life Sciences
Experience in handling, operating and trouble shooting Blister Packing & Liquid Manufacturing & Packing and its documentation.
26 December 2025
Interview for BPharm, MSc in QC, QA, Production & Packing at Akums Drugs and Pharma
B.Pharma / M.Sc. Chemistry work in Solid Orals and Liquid Orals in Akums Drugs and Pharmaceuticals
26 December 2025
New Research finds ADHD Stimulant medications work in unexpected way

Researchers at Washington University School of Medicine in St. Louis suggest that common stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD), such as Ritalin and Adderall, may work in ways scientists didn’t previously understand. The findings challenge the long-held belief that these drugs primarily improve attention by acting directly on the brain’s attention circuits.

26 December 2025
New Global Study Questions Tramadol Use for Long-Term Pain Relief
A new large systematic review published this week has raised important questions about the safety and effectiveness of tramadol, a widely prescribed opioid for chronic pain relief. The study, published online ahead of print in BMJ Evidence-Based Medicine, finds that while tramadol does reduce pain compared with placebo, the benefit is small and may not be clinically meaningful for many patients.
26 December 2025
Sanofi’s moves into adult Vaccines: Buying Dynavax in 2.2 billion USD
In a strategic development that’s set to reshape its vaccine business, Sanofi has announced an agreement to acquire Dynavax Technologies Corporation, a U.S.-based vaccines company known for its marketed adult hepatitis B vaccine and an early-stage shingles vaccine candidate.
26 December 2025
New Hope for Thalassemia Patients as FDA Greenlights Agios’ Aqvesme – But Cautions Remain
A major breakthrough for adults living with rare inherited blood disorders, the U.S. Food and Drug Administration (FDA) has officially approved Agios Pharmaceuticals’ oral drug AQVESME™ (mitapivat) for the treatment of anemia in both alpha- and beta-thalassemia, regardless of whether patients require regular blood transfusions or not.
26 December 2025
Biofabri–Bharat Biotech pact brings fresh hope in global fight against Tuberculosis
Biofabri and Bharat Biotech International Limited have signed a technology transfer agreement aimed at improving worldwide access to the promising TB vaccine candidate, MTBVAC.
Subscribe to